First class in Masters Degree with specialization in Cancer Biology / Epigenetics / Molecular Biology / Cell Biology / Nanoscience and Nanotechnology from a recognized University with good knowledge of molecular biology.

Having good exposure in the OSD facility, documentation and handling equipment such as FBD / FBP / Glatt/ Fette/ Korsch)

Exposure to Leak Test/ Skid Operations/ Filling/ Vial Washing, Exp of Handling Isolator/ VHP Based Filling Area

Diploma/ B Tech, B.sc, MSc, B.Pharm, BTech or Masters in Biotechnology / Microbiology /Biochemistry

Implement and maintain quality control procedures within the QMS framework. Conduct thorough inspections and tests on products and materials at various stages of production

WALK-IN INTERVIEW for Diploma / D.Pharm/ B.Sc / MSc Production, Warehouse & Engineering (OSD Formulations)

Pfizer Inc. announced that it has filed a lawsuit against Metsera, Inc., its Board of Directors, and Novo Nordisk, S.A. in the Delaware Court of Chancery. The lawsuit includes claims for breach of contract, breach of fiduciary duty, and tortious interference in contract arising from Metseras alleged breach of its obligations under the merger agreement between Pfizer and Metsera.

Semaglutide significantly reduced major adverse cardiovascular events in patients with overweight or obesity with cardiovascular disease but without diabetes, as per recent research study conducted by University College London.

The U.S. Food and Drug Administration today announced actions to restrict the sale of unapproved ingestible fluoride prescription drug products for children. The FDA sent notices to four companies outlining the agencys intention to take enforcement action against those marketing unapproved fluoride-containing ingestible drugs labeled for use in children under age 3 or older children at low or moderate risk for tooth decay.

A multiple sclerosis patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalised treatment can slow or even halt the progression of the disease.

MET-I-CON 2026, the 2nd International Conference on Future Trends and Opportunities in the Pharmaceutical World, aims to provide a dynamic platform for advancing pharmaceutical knowledge and innovation.

M.Sc. in Chemistry. Candidates having research experience in the area of catalysis / electrochemistry / in organic/ inorganic synthesis.

Degree or Diploma in Pharmacy (50%) and Live Registration in Pharmacy Registration Council.

A Ph.D. in Pharmaceutical Sciences from a recognized university. First Class at Masters Degree in Pharmacy M.Pharm in relevant specialization.

M.Sc. in any branch of Life Science / Biotechnology / Chemistry / Physics / Microbiology / Agriculture / M.Tech / MPharm with experience in Teaching / Research / Industry.

Excellent academic and research record in the frontiers areas of Plant Biology using modern cell biology and genetics tools. Emphasis towards sustainable agriculture, food security and climate resilience with modern tools such as gene editing. 

M.Sc, M.Tech. or B.Tech 4 years in Microbiology, Biotechnology, Cell Biology, Molecular Biology, Biochemistry or any related areas with a good academic track record. GATE or NET-qualified candidates will be given preference.

First-class Post-Graduate degree in any area of Science, Technology, Engineering, Mathematics with minimum 5 years of experience in coordination and program management in the government, university, research institution.

PhD in Biotechnology / Biomedical Sciences / Biochemistry / Life Sciences or related discipline. Strong foundation in molecular biology techniques including PCR, cloning, vector designing, recombinant DNA technology, and protein expression/purification studies.